Avacta Group PLC Posting of Annual Report & Accounts and AGM Notice (3774A)
December 22 2014 - 2:00AM
UK Regulatory
TIDMAVCT
RNS Number : 3774A
Avacta Group PLC
22 December 2014
Avacta Group plc
("Avacta" or the "Group")
Posting of Annual Report & Accounts and AGM Notice
Avacta Group plc (AIM: AVCT), the global provider of proprietary
diagnostic tools, consumables and reagents for human and animal
healthcare, confirms that the Annual Report and Accounts for the
year ended 31 July 2014, the Notice of the Annual General Meeting
and a Form of Proxy were posted to shareholders on 19 December
2014.
The Annual General Meeting is to be held on 23 January 2015 at
2.00pm at the offices of Walker Morris, Kings Court, 12 King
Street, Leeds, LS1 2HL.
A copy of the Annual Report & Accounts and Notice of Annual
General Meeting is available on the Company's website:
www.avacta.com.
Enquiries:
Avacta Group plc Tel: +44 (0) 844 414
Alastair Smith, Chief Executive Officer 0452
Tim Sykes, Chief Financial Officer www.avacta.com
Numis Securities Limited Tel: +44 (0) 207 260
Michael Meade / Freddie Barnfield - Nominated 1000
Adviser www.numiscorp.com
James Black - Corporate Broking
Media Enquiries Tel: +44 (0) 207 933
Walbrook PR Ltd 8780
Anna Dunphy / Mike Wort avacta@walbrookpr.com
About Avacta Group plc - www.avacta.com
Avacta Group plc is a global provider of innovative
technologies, consumables and reagents for the life science
markets, from drug discovery to diagnostics. Avacta operates
through three divisions:
Avacta Analytical High throughput analysis instrument, Optim,
www.avactaanalytical.com to help reduce the cost and risk of drug development.
--------------------------------------- -------------------------------------------------------
Avacta Animal Health Veterinary diagnostics reference laboratory
www.avactaanimalhealth.com and diagnostic kit provider.
--------------------------------------- -------------------------------------------------------
Avacta Life Sciences Novel non-antibody affinity reagents called
www.avactalifesciences.com Affimers, with a wide range of Life Science
applications in diagnostics, drug and biomarker
discover and biotech research and development.
--------------------------------------- -------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBLBDDLUBBGSC
Avacta (LSE:AVCT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Avacta (LSE:AVCT)
Historical Stock Chart
From Apr 2023 to Apr 2024